4M2 Lymphoma, B cell & sentinel (Case 4) neoplastic area CD3 20X | Sentinel & Steroid Rx Lesions | MYELIN (IMMUNE-MEDIATED)

Washington University Experience | MYELIN (IMMUNE-MEDIATED) | Sentinel & Steroid Rx Lesions | 4M2 Lymphoma, B cell & sentinel (Case 4) neoplastic area CD3 20X

T cell infiltration (CD3 IHC) is also prominent in the same area as the B-cell lymphoma (CD3 IHC)